Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 130 | 139 | +9 |
| Shares | 77.5M | 76.6M | −977.1K (−1.3%) |
| Value | $951.5M | $1.12B | +$166.4M (+17.5%) |
New holders (26)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (17)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Canaan Partners XI LLC | 2,491,561 | $30.6M |
| Commodore Capital LP | 739,661 | $9.08M |
| Verition Fund Management LLC | 548,757 | $6.73M |
| Artal Group S.A. | 500,000 | $6.13M |
| Walleye Capital LLC | 277,206 | $3.40M |
| Trexquant Investment LP | 97,868 | $1.20M |
| AlphaCentric Advisors LLC | 95,000 | $1.17M |
| Millennium Management LLC | 35,786 | $439.1K |
| Apis Capital Advisors, LLC | 29,000 | $355.8K |
| Walleye Trading LLC | 14,966 | $183.6K |
| Capstone Investment Advisors, LLC | 11,088 | $136.1K |
| Group One Trading, L.P. | 2,958 | $36.3K |
| Crewe Advisors LLC | 30 | $369 |
| Advisor Group Holdings, Inc. | 24 | $294 |
| Northwestern Mutual Wealth Management Co | 15 | $184 |
| CWM, LLC | 3 | $0 |
| Avion Wealth | 37 | $0 |